5 Best Medicine for Sinus Infection and Cough 2026 – Tested & Reviewed

The dual-formula approach of Mucinex Sinus-Max Day & Night represents the gold standard for comprehensive sinus and cough management. The day formula combines acetaminophen for pain relief, dextromethorphan for cough suppression, guaifenesin as an expectorant, and phenylephrine for nasal decongestion – delivering maximum strength relief without drowsiness. The night formula swaps guaifenesin for doxylamine succinate, an antihistamine that helps with runny nose, sneezing, and promotes restful sleep.

This intelligent formulation recognizes that sinus infections and cough symptoms behave differently throughout the day. During active hours, you need mucus-thinning action and alert symptom relief. At night, your body requires antihistamine support to manage post-nasal drip and inflammatory responses while enabling restorative sleep. The liquid gel delivery system ensures rapid absorption and onset of action.

Mucinex Sinus-Max Severe delivers the most concentrated attack on intense sinus infection symptoms through its triple-action maximum strength formulation. The combination of acetaminophen for pain and headache relief, guaifenesin as a powerful expectorant to thin and loosen mucus, and phenylephrine as a nasal decongestant creates a comprehensive assault on the three primary mechanisms of sinus misery. This formulation is specifically engineered for those experiencing the peak intensity of sinus infections.

The caplet delivery system, while traditional, provides reliable dosing and extended shelf stability. Each component is dosed at maximum over-the-counter strength levels, making this the go-to choice when symptoms are at their worst. The inclusion of guaifenesin at therapeutic levels ensures productive cough and effective mucus clearance, while phenylephrine provides sustained nasal passage opening.

Vicks Sinex SEVERE represents exceptional value engineering in sinus and cough relief, delivering comprehensive symptom management at an accessible price point. The all-in-one formulation combines a powerful nasal decongestant, effective expectorant, and reliable pain reliever in Vicks' proprietary LiquiCap delivery system. This technology ensures rapid dissolution and absorption, providing faster onset of action compared to traditional tablets.

The non-drowsy formulation is specifically designed for daytime use, allowing users to maintain normal activities while managing severe sinus symptoms. The absence of antihistamines prevents the sedation common in many multi-symptom medications, making it ideal for working adults. The formulation focuses on the core mechanisms of sinus infection relief: reducing inflammation, clearing mucus, and managing pain.

Alka-Seltzer Plus PowerMax distinguishes itself through its comprehensive four-way action specifically designed for allergy-complicated sinus infections. The inclusion of an antihistamine sets it apart from basic decongestant formulations, making it particularly effective when sinus symptoms are triggered or worsened by allergic reactions. This is crucial because many sinus infections begin with allergic inflammation that creates ideal conditions for bacterial growth.

The formulation combines pain reliever/fever reducer, cough suppressant, antihistamine, and nasal decongestant in maximum strength concentrations. This addresses the complex symptom cascade where allergic inflammation leads to congestion, which promotes infection, which causes pain and cough. The antihistamine component specifically targets sneezing, runny nose, and itchy/watery eyes that often accompany allergy-related sinus problems.

WELMATE Mucus Relief delivers exceptional value through its focused approach to the primary mechanism underlying persistent cough and chest congestion: thick, stubborn mucus. The 600mg guaifenesin dosage matches the therapeutic level found in premium brand medications, while the innovative bi-layer tablet technology provides both immediate relief through the first layer and sustained action for up to 12 hours through the extended-release second layer.

This formulation recognizes that effective mucus management requires consistent therapeutic levels of expectorant over extended periods. The 12-hour dosing schedule reduces pill burden while maintaining steady guaifenesin concentrations in the bloodstream. This is particularly important for sinus infections where thick secretions can perpetuate bacterial growth and prolong recovery if not adequately mobilized and cleared.